NL257275A
(da)
|
1959-10-26 |
|
|
|
US3261761A
(en)
|
1962-05-07 |
1966-07-19 |
Arthur W Anderson |
Method of freeze drying bacterial cultures
|
CA1241886A
(en)
|
1983-04-13 |
1988-09-13 |
Peter W. Field |
Enema bag
|
JP2733849B2
(ja)
|
1987-10-12 |
1998-03-30 |
ボロディー,ソーマス・ユリウス |
胃腸障害治療のための改良された方法
|
DE3741180A1
(de)
|
1987-12-04 |
1989-07-06 |
Claus Dr Med Jansen |
Elektroakustischer wandler
|
DE3889547T2
(de)
|
1987-12-24 |
1994-11-17 |
Borody Thomas J |
Orthostatische waschlösungen.
|
CA1333564C
(en)
|
1988-08-02 |
1994-12-20 |
Thomas Julius Borody |
Treatment of gastro-intestinal disorders
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
CA1337265C
(en)
|
1988-08-04 |
1995-10-10 |
Thomas Julius Borody |
Oral antibody therapy for patients with lowered immune response and composition therefor
|
AU650045B2
(en)
|
1990-09-12 |
1994-06-09 |
Lifecell Corporation |
Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
|
US5519014A
(en)
|
1990-10-22 |
1996-05-21 |
Borody; Thomas J. |
Treatment of non-inflammatory and non-infectious bowel disorders
|
ES2213139T5
(es)
|
1990-10-22 |
2011-03-18 |
Centre For Digestive Diseases Pty Ltd |
Tratamiento de trastornos intestinales no inflamatorios.
|
US5229374A
(en)
|
1992-01-28 |
1993-07-20 |
Burton Albert F |
Method for treatment of lower gastrointestinal tract disorders
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US5656283A
(en)
|
1995-06-08 |
1997-08-12 |
Ortho Pharmaceutical Corporation |
In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product
|
WO1997009886A1
(en)
|
1995-09-15 |
1997-03-20 |
Gerding Dale N |
Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
|
US6103268A
(en)
|
1995-11-03 |
2000-08-15 |
Borody; Thomas Julius |
Administering osmotic colonic evacuant containing a picosulfate
|
AUPN634595A0
(en)
|
1995-11-03 |
1995-11-30 |
Borody, Thomas Julius |
Improved method for colonic evacuation
|
US5925354A
(en)
|
1995-11-30 |
1999-07-20 |
Michigan State University |
Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
|
US5711446A
(en)
*
|
1996-01-16 |
1998-01-27 |
Sorenson Bioscience, Inc. |
Cryogenic freezing vial
|
US5902578A
(en)
|
1996-03-25 |
1999-05-11 |
Abbott Laboratories |
Method and formula for the prevention of diarrhea
|
US5837238A
(en)
|
1996-06-05 |
1998-11-17 |
Biogaia Biologics Ab |
Treatment of diarrhea
|
US6096310A
(en)
|
1997-04-15 |
2000-08-01 |
Bier; Milan |
Oral immunotherapy of bacterial overgrowth
|
AUPO665397A0
(en)
|
1997-05-07 |
1997-05-29 |
Borody, Thomas Julius |
Novel therapy for constipation
|
DE69829400T2
(de)
|
1997-10-20 |
2006-04-13 |
Acambis, Inc., Cambridge |
Passive immunisierung gegen durch clostridium difficile verursachte krankheit
|
US6969520B2
(en)
|
1997-10-20 |
2005-11-29 |
Acambis Inc. |
Active immunization against clostridium difficile disease
|
US6428783B1
(en)
|
1998-03-11 |
2002-08-06 |
Medtech Center, Inc. |
Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
US6395467B1
(en)
|
1998-09-21 |
2002-05-28 |
Gregory M. Fahy |
Cryoprotectant solution containing dimethyl sulfoxide, an amide and ethylene glycol
|
ID29150A
(id)
*
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
US7430478B2
(en)
*
|
2000-03-01 |
2008-09-30 |
Caridian Bct, Inc. |
Blood processing information system with blood loss equivalency tracking
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
JP2001327280A
(ja)
|
2000-05-23 |
2001-11-27 |
Lion Corp |
菌用凍結保存液
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
US20040062757A1
(en)
|
2001-06-05 |
2004-04-01 |
Finegold Sydney M. |
Method of testing gastrointestinal diseases associated with species of genus clostridium
|
JP2003535903A
(ja)
|
2000-06-19 |
2003-12-02 |
ミューコプロテック・プロプライエタリー・リミテッド |
プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
|
CA2416120A1
(en)
|
2000-07-17 |
2002-01-24 |
Svend Laulund |
Methods and formulations with probiotic microorganisms and medicaments
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
US7192724B2
(en)
|
2000-11-14 |
2007-03-20 |
Techlab, Inc. |
Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker
|
EP1339390A2
(en)
|
2000-12-06 |
2003-09-03 |
Pharmacia Corporation |
Laboratory scale milling process
|
NZ530765A
(en)
|
2001-06-26 |
2006-11-30 |
Amgen Fremont Inc |
Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
|
EP1428018B1
(en)
|
2001-09-06 |
2010-06-09 |
Straus Holdings Inc. |
Rapid and sensitive detection of molecules
|
EP1300472A1
(en)
|
2001-10-02 |
2003-04-09 |
Stichting Top-Instituut Voedselwetenschappen |
A method for testing the effect of nutrients on gastrointestinal colonisation resistance of humans
|
GB0124580D0
(en)
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
AU2002360532A1
(en)
*
|
2001-12-10 |
2003-06-23 |
Ardais Corporation |
Systems and methods for obtaining data correlated patient samples
|
US20030161871A1
(en)
|
2001-12-19 |
2003-08-28 |
Geoffrey Hird |
Solubilized riboflavin
|
AUPS088702A0
(en)
|
2002-03-04 |
2002-03-28 |
Borody, Thomas Julius |
Electrolyte purgative
|
JP2006504446A
(ja)
|
2002-03-26 |
2006-02-09 |
グラクソ グループ リミテッド |
ラミネート・アセンブリーの形成方法、およびそれにより形成される製品
|
US20040265291A1
(en)
|
2003-01-24 |
2004-12-30 |
Flora Technology Inc. |
Compositions and methods for restoring bacterial flora
|
GB0322791D0
(en)
|
2003-09-30 |
2003-10-29 |
Lifeforce Group Plc |
Blood co-processing for contingent autologous leukocyte transplantation
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
US20060008511A1
(en)
|
2004-07-08 |
2006-01-12 |
Jhy-Jhu Lin |
Probiotic products for pet applications
|
US7935334B2
(en)
|
2005-07-07 |
2011-05-03 |
Imagilin Technologies, LLC |
Probiotics as alternative medicines against infectious diseases
|
US7909806B2
(en)
|
2004-09-23 |
2011-03-22 |
Anthrogenesis Corporation |
Cord blood and placenta collection kit
|
AU2005335216A1
(en)
|
2004-10-05 |
2007-02-15 |
Wyeth |
Probe arrays for detecting multiple strains of different species
|
EP1828953B1
(en)
|
2004-11-08 |
2013-03-06 |
Yale University Corporation |
Crystalline xpt guanine riboswitch from Bacillus subtilis and structure-based compound identification employing said riboswitch
|
US20080075901A1
(en)
|
2005-02-23 |
2008-03-27 |
Lee S Thomas |
Multilayer Films Including Cycloolefin Copolymer and Styrene-Butadiene Copolymer
|
US20060210448A1
(en)
|
2005-03-10 |
2006-09-21 |
Naishu Wang |
Fecal specimen collection, preserving and transport device and method
|
AU2006224760A1
(en)
|
2005-03-17 |
2006-09-21 |
Synthon B.V. |
Pharmaceutical tablets of crystalline Type II aripiprazole
|
US7607776B1
(en)
|
2005-10-24 |
2009-10-27 |
James Waller Lambuth Lewis |
Digital eye bank for virtual clinic trials
|
US8313901B2
(en)
|
2005-12-21 |
2012-11-20 |
Yale University |
Methods and compositions related to the modulation of riboswitches
|
ATE541469T1
(de)
|
2005-12-29 |
2012-02-15 |
Hills Pet Nutrition Inc |
Verfahren zum modifizieren der darmflora bei tieren
|
US20080008751A1
(en)
|
2006-07-10 |
2008-01-10 |
Michael Fox |
Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
|
US20080027353A1
(en)
|
2006-07-31 |
2008-01-31 |
Kliman Harvey J |
Method of making and using a library of biological information
|
WO2008062467A2
(en)
|
2006-10-13 |
2008-05-29 |
Reliance Life Sciences Pvt. Ltd. |
Cultured melanocytes on biopolymers
|
US20100172874A1
(en)
|
2006-12-18 |
2010-07-08 |
The Washington University |
Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
ES2628973T3
(es)
|
2007-05-31 |
2017-08-04 |
University Of Washington |
Mutagénesis inducible de genes diana
|
EP2030623A1
(en)
|
2007-08-17 |
2009-03-04 |
Nestec S.A. |
Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
|
WO2009042642A2
(en)
|
2007-09-24 |
2009-04-02 |
President And Fellows Of Harvard College |
Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer
|
AU2008317000B2
(en)
|
2007-10-26 |
2014-10-23 |
Brenda E. Moore |
Probiotic compositions and methods for inducing and supporting weight loss
|
US20090138354A1
(en)
|
2007-11-25 |
2009-05-28 |
Herbert Zech |
Methods of Storing and Providing Samples of Cells and Tissue
|
US20090148540A1
(en)
|
2007-12-10 |
2009-06-11 |
Mi Hope Incorporated |
Antibacterial composition and method of production
|
US8338812B2
(en)
|
2008-01-16 |
2012-12-25 |
Micron Technology, Inc. |
Vertical spacer electrodes for variable-resistance material memories and vertical spacer variable-resistance material memory cells
|
WO2009120347A2
(en)
|
2008-03-27 |
2009-10-01 |
Memorial Sloan Kettering Cancer Center |
Modulators of rna riboswitches
|
US20110177976A1
(en)
|
2008-06-30 |
2011-07-21 |
The Washington University |
Methods for promoting weight loss and associated arrays
|
US20100008850A1
(en)
|
2008-07-14 |
2010-01-14 |
William John Martin |
Method of generating hydrogen in drinking water using an enerceutical product added to magnesium in a hydrogen permeable but solute impermeable container
|
CN102159084B
(zh)
|
2008-07-17 |
2014-07-23 |
生物工厂公司 |
利用绿木霉物种与根际活性的哈茨木霉物种的组合来控制植物疾病与增强植物生长
|
CN102176825A
(zh)
|
2008-08-11 |
2011-09-07 |
佰欧莱利克斯公司 |
黄素衍生物
|
AU2009313867A1
(en)
|
2008-11-14 |
2011-06-30 |
Patheon Inc. |
Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low pH and methods of use thereof
|
US20110240511A1
(en)
|
2008-12-10 |
2011-10-06 |
Merck Sharp & Dohme Corp. |
Packaging for oxygen-sensitive pharmaceutical products
|
EP2424503B1
(en)
|
2009-05-01 |
2017-07-05 |
Ferring BV |
Composition for the treatment of prostate cancer
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
AU2010299552A1
(en)
|
2009-09-23 |
2012-04-05 |
Thomas Julius Borody |
Therapy for enteric infections
|
AU2010310892B2
(en)
|
2009-10-22 |
2015-07-02 |
Thomas Julius Borody |
Novel parasite therapy
|
AU2010312309B2
(en)
|
2009-10-26 |
2016-10-06 |
Thomas Julius Borody |
Novel enteric combination therapy
|
DK3564357T3
(da)
|
2010-02-01 |
2022-06-20 |
Rebiotix Inc |
Bakterieterapi mod clostridium difficile colitis
|
US8853269B2
(en)
|
2010-02-04 |
2014-10-07 |
Copperhead Chemical Company Inc. |
Composition and method for treating infections and promoting intestinal health
|
EP2542695A2
(en)
|
2010-03-01 |
2013-01-09 |
Institut National de la Recherche Agronomique |
Method of diagnostic of obesity
|
AU2011223049B2
(en)
|
2010-03-01 |
2015-06-18 |
Institut National De La Recherche Agronomique |
Method of diagnostic of inflammatory bowel diseases
|
FI20105478A0
(fi)
|
2010-04-30 |
2010-04-30 |
Valtion Teknillinen |
Menetelmä tyypin 1 diabeteksen diagnosoimiseksi ja menetelmiä ja koostumuksia tyypin 1 diabeteksen puhkeamisen estämiseksi
|
US9707207B2
(en)
|
2010-05-26 |
2017-07-18 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Method for diagnosing, preventing, and treating neurological diseases
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
WO2012013861A2
(en)
|
2010-07-26 |
2012-02-02 |
Suomen Punainen Risti Veripalvelu |
Use of blood group status iii
|
FI20105825A
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
KR20130098320A
(ko)
|
2010-08-04 |
2013-09-04 |
토마스 줄리어스 보로디 |
분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
AU2011299285B2
(en)
|
2010-09-10 |
2017-01-05 |
Ntcd, Llc |
Environmental Clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
WO2012050513A1
(en)
|
2010-10-11 |
2012-04-19 |
Baeckhed Fredrik |
Method for identifying a risk of cardiovascular disease by analysing oral microbiota
|
CN103687604A
(zh)
|
2011-03-01 |
2014-03-26 |
群体创新有限责任公司 |
用于治疗与致病生物膜相关之病症的材料和方法
|
EP2683390B1
(en)
|
2011-03-09 |
2017-05-03 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2014152484A1
(en)
|
2013-03-14 |
2014-09-25 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
US20120276059A1
(en)
|
2011-04-29 |
2012-11-01 |
Techlab, Inc. |
Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
|
WO2012159023A2
(en)
|
2011-05-19 |
2012-11-22 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
EP2748330A1
(en)
|
2011-08-26 |
2014-07-02 |
Microbiota Diagnostics, LLC |
Methods for diagnosing and treating cardiac defects
|
CA2848757C
(en)
|
2011-09-14 |
2021-11-09 |
University Of Guelph |
Methods to culture human gastrointestinal microorganisms
|
CN103857402A
(zh)
|
2011-10-11 |
2014-06-11 |
阿基姆医药公司 |
包括厌氧培养的人类肠道微生物群的组合物
|
ES2726534T3
(es)
|
2011-11-09 |
2019-10-07 |
Capsugel Belgium Nv |
Disolución de precintado resistente a ácido para cápsulas duras de dos piezas resistentes a ácido
|
WO2013090825A1
(en)
|
2011-12-15 |
2013-06-20 |
Pureflora, Inc. |
Device for the collection, refinement, and administration of gastrointestinal microflora
|
CN110201003A
(zh)
|
2012-02-29 |
2019-09-06 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
EP2636684A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Prevention of infection
|
US9421233B2
(en)
|
2012-04-27 |
2016-08-23 |
Cedars-Sinai Medical Center |
Fungal mycobiome as probiotics, diagnostics and therapeutics
|
DK2850202T3
(da)
|
2012-05-18 |
2020-05-18 |
Genome Res Ltd |
Fremgangsmåder og grupper
|
BR112014032948A2
(pt)
|
2012-07-02 |
2017-06-27 |
Dsm Ip Assets Bv |
cápsulas contendo timoquinona
|
US20140112985A1
(en)
|
2012-10-22 |
2014-04-24 |
Polonez Therapeutics Llc |
Method of prevention and treatment of clostridium difficile infection
|
CN104955466A
(zh)
|
2012-11-23 |
2015-09-30 |
赛里斯治疗公司 |
协同细菌组合物和其制造方法和用途
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
EP2922555A4
(en)
|
2012-11-26 |
2016-06-15 |
Borody Thomas J |
COMPOSITIONS FOR THE RESTORATION OF AN FECAL MICROBIOTE AND METHODS OF MAKING AND USING THEM
|
JP6491102B2
(ja)
|
2012-11-29 |
2019-03-27 |
プロゲル プロプライアタリー リミティド |
プロバイオティクス、架橋性試薬、変性タンパク質、ポリオール可塑剤及びトレハロースを含む微小粒子
|
US9689602B2
(en)
|
2012-12-23 |
2017-06-27 |
Illuminate Consulting, Llc |
Method and apparatus for thermally protecting and/or transporting temperature sensitive products
|
JP6479685B2
(ja)
|
2013-02-04 |
2019-03-06 |
セレス セラピューティクス インコーポレイテッド |
病原性細菌生育の抑制のための組成物および方法
|
EP3904502A3
(en)
|
2013-02-04 |
2022-02-23 |
Seres Therapeutics, Inc. |
Compositions and methods
|
US9192361B2
(en)
|
2013-02-26 |
2015-11-24 |
Christopher J Stevens |
Fecal microbiome transplant material preparation method and apparatus
|
WO2014153194A2
(en)
|
2013-03-14 |
2014-09-25 |
Seres Health, Inc. |
Methods for pathogen detection and enrichment from materials and compositions
|
CA2906921A1
(en)
|
2013-03-15 |
2014-09-18 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
EP4234011A3
(en)
|
2013-06-05 |
2023-09-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US20150037285A1
(en)
|
2013-07-03 |
2015-02-05 |
New York University |
Methods for efficient transfer of viable and bioactive microbiota
|
WO2015026235A2
(en)
|
2013-08-22 |
2015-02-26 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno |
Production of probiotics by in vitro enrichment of beneficial microorganisms from human or animal microbiota
|
JP2015091647A
(ja)
|
2013-09-30 |
2015-05-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
マーキング方法、レーザー転写フィルム、インク組成物、マークが施された転写対象可食物及びその製造方法
|
EP3294307A4
(en)
|
2015-05-14 |
2019-01-23 |
Crestovo Holdings Llc |
COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION
|
NZ776366A
(en)
|
2015-05-22 |
2023-02-24 |
Univ Minnesota |
Methods for treating autism spectrum disorder and associated symptoms
|
WO2016196605A1
(en)
|
2015-06-01 |
2016-12-08 |
The University Of Chicago |
Treatment of cancer by manipulation of commensal microflora
|
AU2016274757B2
(en)
|
2015-06-09 |
2019-02-07 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10173160B2
(en)
|
2015-10-09 |
2019-01-08 |
Heinzen, Llc |
Effluent removal system and method of use
|
ITUB20169847A1
(it)
|
2016-01-05 |
2017-07-05 |
Wellmicro S R L |
Metodo per valutare lo stato di salute di un individuo
|
US20180000872A1
(en)
|
2016-07-01 |
2018-01-04 |
Regents Of The University Of Minnesota |
Compositions and methods for c. difficile treatment
|
WO2020018668A1
(en)
|
2018-07-17 |
2020-01-23 |
Ferring B.V. |
Combination therapy comprising microbiota restoration therapy (mrt) compositions
|